CXCL14 and lung carcinoma: Analysing a prospective cohort of blood samples from lung cancer patients across different stages, we uncovered that CXCL14 in plasma predicted the occurrence of metastasis and demonstrated similar diagnostic efficacy to typical tumour markers (e.g., CEA, Cyfra21‐1, SCC, etc.).